Reliance Industries share price to be in focus on Thursday. Here's why

Reliance Industries' step-down subsidiary Karkinos Healthcare has completed HPV DNA cervical cancer screening for over one lakh women across India. The article notes RIL shares have lost 16.5% year-to-date, weighing on the Nifty 50 given its heavyweight index status. Earlier in the week, Chairman Mukesh Ambani at the AGM outlined plans to double consolidated EBITDA over five years, target one trillion rupees in gross revenue for the FMCG arm by FY30, and enable $125 billion to $150 billion in exports by 2032, with brokerages retaining a bullish outlook.